Literature DB >> 11992569

Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease.

Guomei Tang1, Huijun Xie, Lin Xu, Yixin Hao, Dayu Lin, Daming Ren.   

Abstract

Several lines of evidence have suggested some common genetic risk factors for Alzheimer disease (AD) and Parkinson disease (PD) because there are some overlapping pathologies in these two neurodegenerative diseases. In the present study, we investigated the role of Apolipoprotein E gene polymorphism and the signal peptide polymorphism in alpha-1 antichymotrypsin (ACT) gene in idiopathic sporadic PD. The study was performed in a sample consisting of 68 PD cases and 160 healthy subjects in Shanghai China. We found no significant differences of ACT gene polymorphic distribution between PD cases and controls. The ApoE gene epsilon2/epsilon4 genotype was significantly more frequent in PD subjects (chi2 = 7.126, df = 1, P = 0.008) and conferred a 12.70 times susceptibility for PD (OR = 12.62, 95% CI: 1.445-110.17, chi2 = 5.259, P < 0.05, AF = 4.59%). No interaction of ApoE and ACT genes was detected in PD. Therefore, our data suggested that the ApoE epsilon2/epsilon4 genotype might be a susceptibility variant of moderate effect for sporadic idiopathic PD in our samples, whereas the ACT gene signal peptide polymorphism might not. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992569     DOI: 10.1002/ajmg.10249

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  11 in total

1.  Parkinson's disease in China.

Authors:  You-yong Tian; Cui-ju Tang; Jie Wu; Jun-shan Zhou
Journal:  Neurol Sci       Date:  2010-12-14       Impact factor: 3.307

2.  APOE and CYP2E1 polymorphisms, alcohol consumption, and Parkinson's disease in a Japanese population.

Authors:  Chikako Kiyohara; Yoshihiro Miyake; Midori Koyanagi; Takahiro Fujimoto; Senji Shirasawa; Keiko Tanaka; Wakaba Fukushima; Satoshi Sasaki; Yoshio Tsuboi; Tatsuo Yamada; Tomoko Oeda; Takami Miki; Nobutoshi Kawamura; Nobutaka Sakae; Hidenao Fukuyama; Yoshio Hirota; Masaki Nagai
Journal:  J Neural Transm (Vienna)       Date:  2011-03-01       Impact factor: 3.575

3.  APOE and LRPAP1 gene polymorphism and risk of Parkinson's disease.

Authors:  Neeraj Kumar Singh; Basu Dev Banerjee; Kiran Bala; Aldrin Anthony Dung Dung; Neelam Chhillar
Journal:  Neurol Sci       Date:  2014-02-07       Impact factor: 3.307

4.  ApoE isoform-dependent deficits in extinction of contextual fear conditioning.

Authors:  R H J Olsen; M Agam; M J Davis; J Raber
Journal:  Genes Brain Behav       Date:  2012-09-07       Impact factor: 3.449

Review 5.  AR, apoE, and cognitive function.

Authors:  Jacob Raber
Journal:  Horm Behav       Date:  2008-02-26       Impact factor: 3.587

6.  Detection of apolipoprotein E phenotype in unconcentrated cerebrospinal fluid.

Authors:  P D Mehta; B A Patrick; T Pirttila; P K Coyle; P S Aisen
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

7.  Proinflammatory actions of glucocorticoids: glucocorticoids and TNFα coregulate gene expression in vitro and in vivo.

Authors:  Erica A Lannan; Amy J Galliher-Beckley; Alyson B Scoltock; John A Cidlowski
Journal:  Endocrinology       Date:  2012-06-06       Impact factor: 4.736

8.  Function and comorbidities of apolipoprotein e in Alzheimer's disease.

Authors:  Valérie Leduc; Dorothée Domenger; Louis De Beaumont; Daphnée Lalonde; Stéphanie Bélanger-Jasmin; Judes Poirier
Journal:  Int J Alzheimers Dis       Date:  2011-04-05

Review 9.  Genetics of Parkinson's disease - a clinical perspective.

Authors:  Sang-Myung Cheon; Lilian Chan; Daniel Kam Yin Chan; Jae Woo Kim
Journal:  J Mov Disord       Date:  2012-10-30

10.  The genetic association between apolipoprotein E gene polymorphism and Parkinson disease: A meta-Analysis of 47 studies.

Authors:  Jianming Li; Jia Luo; Li Liu; Hui Fu; Liang Tang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.